Cargando…

Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies

Neutralizing antibody responses to coronaviruses mainly target the receptor-binding domain (RBD) of the trimeric spike. Here, we characterized polyclonal immunoglobulin Gs (IgGs) and Fabs from COVID-19 convalescent individuals for recognition of coronavirus spikes. Plasma IgGs differed in their focu...

Descripción completa

Detalles Bibliográficos
Autores principales: Barnes, Christopher O., West, Anthony P., Huey-Tubman, Kathryn E., Hoffmann, Magnus A.G., Sharaf, Naima G., Hoffman, Pauline R., Koranda, Nicholas, Gristick, Harry B., Gaebler, Christian, Muecksch, Frauke, Lorenzi, Julio C. Cetrulo, Finkin, Shlomo, Hägglöf, Thomas, Hurley, Arlene, Millard, Katrina G., Weisblum, Yiska, Schmidt, Fabian, Hatziioannou, Theodora, Bieniasz, Paul D., Caskey, Marina, Robbiani, Davide F., Nussenzweig, Michel C., Bjorkman, Pamela J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cell Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7311918/
https://www.ncbi.nlm.nih.gov/pubmed/32645326
http://dx.doi.org/10.1016/j.cell.2020.06.025
_version_ 1783549619720945664
author Barnes, Christopher O.
West, Anthony P.
Huey-Tubman, Kathryn E.
Hoffmann, Magnus A.G.
Sharaf, Naima G.
Hoffman, Pauline R.
Koranda, Nicholas
Gristick, Harry B.
Gaebler, Christian
Muecksch, Frauke
Lorenzi, Julio C. Cetrulo
Finkin, Shlomo
Hägglöf, Thomas
Hurley, Arlene
Millard, Katrina G.
Weisblum, Yiska
Schmidt, Fabian
Hatziioannou, Theodora
Bieniasz, Paul D.
Caskey, Marina
Robbiani, Davide F.
Nussenzweig, Michel C.
Bjorkman, Pamela J.
author_facet Barnes, Christopher O.
West, Anthony P.
Huey-Tubman, Kathryn E.
Hoffmann, Magnus A.G.
Sharaf, Naima G.
Hoffman, Pauline R.
Koranda, Nicholas
Gristick, Harry B.
Gaebler, Christian
Muecksch, Frauke
Lorenzi, Julio C. Cetrulo
Finkin, Shlomo
Hägglöf, Thomas
Hurley, Arlene
Millard, Katrina G.
Weisblum, Yiska
Schmidt, Fabian
Hatziioannou, Theodora
Bieniasz, Paul D.
Caskey, Marina
Robbiani, Davide F.
Nussenzweig, Michel C.
Bjorkman, Pamela J.
author_sort Barnes, Christopher O.
collection PubMed
description Neutralizing antibody responses to coronaviruses mainly target the receptor-binding domain (RBD) of the trimeric spike. Here, we characterized polyclonal immunoglobulin Gs (IgGs) and Fabs from COVID-19 convalescent individuals for recognition of coronavirus spikes. Plasma IgGs differed in their focus on RBD epitopes, recognition of alpha- and beta-coronaviruses, and contributions of avidity to increased binding/neutralization of IgGs over Fabs. Using electron microscopy, we examined specificities of polyclonal plasma Fabs, revealing recognition of both S1(A) and RBD epitopes on SARS-CoV-2 spike. Moreover, a 3.4 Å cryo-electron microscopy (cryo-EM) structure of a neutralizing monoclonal Fab-spike complex revealed an epitope that blocks ACE2 receptor binding. Modeling based on these structures suggested different potentials for inter-spike crosslinking by IgGs on viruses, and characterized IgGs would not be affected by identified SARS-CoV-2 spike mutations. Overall, our studies structurally define a recurrent anti-SARS-CoV-2 antibody class derived from VH3-53/VH3-66 and similarity to a SARS-CoV VH3-30 antibody, providing criteria for evaluating vaccine-elicited antibodies.
format Online
Article
Text
id pubmed-7311918
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Cell Press
record_format MEDLINE/PubMed
spelling pubmed-73119182020-06-24 Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies Barnes, Christopher O. West, Anthony P. Huey-Tubman, Kathryn E. Hoffmann, Magnus A.G. Sharaf, Naima G. Hoffman, Pauline R. Koranda, Nicholas Gristick, Harry B. Gaebler, Christian Muecksch, Frauke Lorenzi, Julio C. Cetrulo Finkin, Shlomo Hägglöf, Thomas Hurley, Arlene Millard, Katrina G. Weisblum, Yiska Schmidt, Fabian Hatziioannou, Theodora Bieniasz, Paul D. Caskey, Marina Robbiani, Davide F. Nussenzweig, Michel C. Bjorkman, Pamela J. Cell Article Neutralizing antibody responses to coronaviruses mainly target the receptor-binding domain (RBD) of the trimeric spike. Here, we characterized polyclonal immunoglobulin Gs (IgGs) and Fabs from COVID-19 convalescent individuals for recognition of coronavirus spikes. Plasma IgGs differed in their focus on RBD epitopes, recognition of alpha- and beta-coronaviruses, and contributions of avidity to increased binding/neutralization of IgGs over Fabs. Using electron microscopy, we examined specificities of polyclonal plasma Fabs, revealing recognition of both S1(A) and RBD epitopes on SARS-CoV-2 spike. Moreover, a 3.4 Å cryo-electron microscopy (cryo-EM) structure of a neutralizing monoclonal Fab-spike complex revealed an epitope that blocks ACE2 receptor binding. Modeling based on these structures suggested different potentials for inter-spike crosslinking by IgGs on viruses, and characterized IgGs would not be affected by identified SARS-CoV-2 spike mutations. Overall, our studies structurally define a recurrent anti-SARS-CoV-2 antibody class derived from VH3-53/VH3-66 and similarity to a SARS-CoV VH3-30 antibody, providing criteria for evaluating vaccine-elicited antibodies. Cell Press 2020-08-20 /pmc/articles/PMC7311918/ /pubmed/32645326 http://dx.doi.org/10.1016/j.cell.2020.06.025 Text en © 2020 The Author(s) http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Barnes, Christopher O.
West, Anthony P.
Huey-Tubman, Kathryn E.
Hoffmann, Magnus A.G.
Sharaf, Naima G.
Hoffman, Pauline R.
Koranda, Nicholas
Gristick, Harry B.
Gaebler, Christian
Muecksch, Frauke
Lorenzi, Julio C. Cetrulo
Finkin, Shlomo
Hägglöf, Thomas
Hurley, Arlene
Millard, Katrina G.
Weisblum, Yiska
Schmidt, Fabian
Hatziioannou, Theodora
Bieniasz, Paul D.
Caskey, Marina
Robbiani, Davide F.
Nussenzweig, Michel C.
Bjorkman, Pamela J.
Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies
title Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies
title_full Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies
title_fullStr Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies
title_full_unstemmed Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies
title_short Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies
title_sort structures of human antibodies bound to sars-cov-2 spike reveal common epitopes and recurrent features of antibodies
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7311918/
https://www.ncbi.nlm.nih.gov/pubmed/32645326
http://dx.doi.org/10.1016/j.cell.2020.06.025
work_keys_str_mv AT barneschristophero structuresofhumanantibodiesboundtosarscov2spikerevealcommonepitopesandrecurrentfeaturesofantibodies
AT westanthonyp structuresofhumanantibodiesboundtosarscov2spikerevealcommonepitopesandrecurrentfeaturesofantibodies
AT hueytubmankathryne structuresofhumanantibodiesboundtosarscov2spikerevealcommonepitopesandrecurrentfeaturesofantibodies
AT hoffmannmagnusag structuresofhumanantibodiesboundtosarscov2spikerevealcommonepitopesandrecurrentfeaturesofantibodies
AT sharafnaimag structuresofhumanantibodiesboundtosarscov2spikerevealcommonepitopesandrecurrentfeaturesofantibodies
AT hoffmanpauliner structuresofhumanantibodiesboundtosarscov2spikerevealcommonepitopesandrecurrentfeaturesofantibodies
AT korandanicholas structuresofhumanantibodiesboundtosarscov2spikerevealcommonepitopesandrecurrentfeaturesofantibodies
AT gristickharryb structuresofhumanantibodiesboundtosarscov2spikerevealcommonepitopesandrecurrentfeaturesofantibodies
AT gaeblerchristian structuresofhumanantibodiesboundtosarscov2spikerevealcommonepitopesandrecurrentfeaturesofantibodies
AT mueckschfrauke structuresofhumanantibodiesboundtosarscov2spikerevealcommonepitopesandrecurrentfeaturesofantibodies
AT lorenzijulioccetrulo structuresofhumanantibodiesboundtosarscov2spikerevealcommonepitopesandrecurrentfeaturesofantibodies
AT finkinshlomo structuresofhumanantibodiesboundtosarscov2spikerevealcommonepitopesandrecurrentfeaturesofantibodies
AT hagglofthomas structuresofhumanantibodiesboundtosarscov2spikerevealcommonepitopesandrecurrentfeaturesofantibodies
AT hurleyarlene structuresofhumanantibodiesboundtosarscov2spikerevealcommonepitopesandrecurrentfeaturesofantibodies
AT millardkatrinag structuresofhumanantibodiesboundtosarscov2spikerevealcommonepitopesandrecurrentfeaturesofantibodies
AT weisblumyiska structuresofhumanantibodiesboundtosarscov2spikerevealcommonepitopesandrecurrentfeaturesofantibodies
AT schmidtfabian structuresofhumanantibodiesboundtosarscov2spikerevealcommonepitopesandrecurrentfeaturesofantibodies
AT hatziioannoutheodora structuresofhumanantibodiesboundtosarscov2spikerevealcommonepitopesandrecurrentfeaturesofantibodies
AT bieniaszpauld structuresofhumanantibodiesboundtosarscov2spikerevealcommonepitopesandrecurrentfeaturesofantibodies
AT caskeymarina structuresofhumanantibodiesboundtosarscov2spikerevealcommonepitopesandrecurrentfeaturesofantibodies
AT robbianidavidef structuresofhumanantibodiesboundtosarscov2spikerevealcommonepitopesandrecurrentfeaturesofantibodies
AT nussenzweigmichelc structuresofhumanantibodiesboundtosarscov2spikerevealcommonepitopesandrecurrentfeaturesofantibodies
AT bjorkmanpamelaj structuresofhumanantibodiesboundtosarscov2spikerevealcommonepitopesandrecurrentfeaturesofantibodies